<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03895177</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH-2019-0140</org_study_id>
    <nct_id>NCT03895177</nct_id>
  </id_info>
  <brief_title>Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT</brief_title>
  <official_title>Usefulness of Low kVp High mAs Computed Tomography for the Evaluation of Pancreatic Cancer Resectability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate usefulness of low kVp high mAs computed tomography in
      evaluation of pancreatic cancer resectability.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>accuracy of low kVp CT to assess R0 resection of pancreatic cancer</measure>
    <time_frame>2 weeks after surgery</time_frame>
    <description>Pancreastic cancer resectability</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">147</enrollment>
  <condition>Diagnoses Disease</condition>
  <arm_group>
    <arm_group_label>low kVp high mAs CT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>doing pancreatic CT with 80 kVp tube current with more than 500 mA tube current for the evaluation of pancreatic cancer resectability</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>contrast enhanced computed tomography</intervention_name>
    <description>pancreatic protocol CT with 80kVp tube voltage and more than 500mA tube current acquire late arterial phase and portal venous phase using volus tracking method</description>
    <arm_group_label>low kVp high mAs CT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. age between 20 year-old and 85 year-old 2. patient with pancreatic cancer detected
             on standard CT scan using 120 kVp that obtained within one month 3. consider surgical
             resection for pancreatic cancer treatment 4. patients who can undergo contrast
             enhanced CT scan

        Exclusion Criteria:

          -  1. history of severe adverse reaction to iodine contrast 2. less than 60 of estimated
             GFR
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Ho Lee, M.D.</last_name>
      <phone>82-2-2072-0348</phone>
      <email>dhlee.rad@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jeong Min Lee, M.D.</last_name>
      <phone>82-2-2072-3154</phone>
      <email>jmsh@snu.ac.kr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2019</study_first_posted>
  <last_update_submitted>March 27, 2019</last_update_submitted>
  <last_update_submitted_qc>March 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jeong Min Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

